最新消息

News & Message

:::
首頁/
最新消息/
期刊論文

最新消息

最新消息

期刊論文

目前搜尋條件：全院文章
Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

2026/2/3
Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

2026/2/3
Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

2026/2/3
INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

2026/2/3
Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer

Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer

2026/2/3
 Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the Taiwan Bronchiectasis Research Collaboration

 Cardiovascular disease as a prognostic factor for mortality in non-cystic fibrosis bronchiectasis: data from the Taiwan Bronchiectasis Research Collaboration

2025/12/1
 Outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections in intensive care units and prognostic effect of different antimicrobial regimens

 Outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections in intensive care units and prognostic effect of different antimicrobial regimens

2025/10/31
 An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trial

 An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trial

2025/10/1
 Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors

 Real-World Evidence That Non-Smokers With High PD-L1 Non-Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors

2025/9/30
 High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection

 High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection

2025/8/30
側邊開關圖示開關
首頁 Facebook Instagram 體系醫院 中國醫點通
▲至頂
分享到： 文心一言 百度知道 支付宝 微博 QQ空间 QQ 豆瓣 知乎 CSDN 博客园 简书 百家号 搜狐号 网易号 腾讯
百度 搜狗 360搜索 八零娇女一撒娇,高冷军少领证了 直播丨尹锡悦缺席弹劾案宣判，能否闯过“生死关”？ 龙之家族 巴克莱：美国关税对欧盟汽车业更糟 重回我爸当校草那几年 
      <code id='e60f3'></code><style id='0b68e'></style>
      • <acronym id='2a295'></acronym>
      <center id='b0a0f'><center id='3ffeb'><tfoot id='21bc4'></tfoot></center><abbr id='a3cbb'><dir id='e6a35'><tfoot id='8a94b'></tfoot><noframes id='28a35'>
      • <optgroup id='4a679'><strike id='3d018'><sup id='52db2'></sup></strike><code id='1e404'></code></optgroup>
        5. <b id='59963'><label id='361a4'><select id='c7c24'><dt id='da39c'><span id='76adc'></span></dt></select></label></b><u id='75f06'></u>
          <i id='a96e4'><strike id='e415c'><tt id='f70ca'><pre id='12243'></pre></tt></strike></i>